{{Rsnum
|rsid=1896731
|Chromosome=5
|position=25898911
|Orientation=plus
|GMAF=0.4449
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 13.3 | 46.9 | 39.8
| HCB | 42.3 | 38.0 | 19.7
| JPT | 32.7 | 50.4 | 16.8
| YRI | 15.6 | 44.2 | 40.1
| ASW | 15.8 | 59.6 | 24.6
| CHB | 42.3 | 38.0 | 19.7
| CHD | 26.6 | 57.8 | 15.6
| GIH | 15.8 | 45.5 | 38.6
| LWK | 27.3 | 48.2 | 24.5
| MEX | 19.0 | 44.8 | 36.2
| MKK | 32.7 | 43.6 | 23.7
| TSI | 10.8 | 49.0 | 40.2
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1896731
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19404256
|Annotation=This SNP on 5p14.1 was associated with autism spectrum disorder in a combined analysis of four GWAS data sets with a total of more than 10,000 subjects of European ancestry. This SNP is in an intergenic region between CDH10 and CDH9 that contains several highly conserved genomic elements.
|Drugs=
|Drug Classes=
|Diseases=Autism Spectrum Disorder
|Curation Level=Curated
|PharmGKB Accession ID=PA164741099
}}

{{PMID Auto
|PMID=19456320
|Title=A genome-wide association study of autism reveals a common novel risk locus at 5p14.1.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1896731
|overall_frequency_n=56
|overall_frequency_d=128
|overall_frequency=0.4375
|n_genomes=42
|n_genomes_annotated=0
|n_haplomes=53
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}